The Twofold Trouble–A Case of Fissured Tongue Syndrome
P Geon, RK Roopashri, K Raghavendra, KR Prasanna… - World Scientific News, 2018
… Oral Health and Care. 2017; 2(2): 1. [2] Assimakopoulos D, Patrikakos G, Fotika C, Elisaf M. Benign
Migratory Glossitis or Geographic Tongue: An Enigmatic Oral Lesion. Am J Med … [4] Goswami M,
Verma A, Verma M. Benign migratory glossitis with fissured tongue …
Migratory Glossitis or Geographic Tongue: An Enigmatic Oral Lesion. Am J Med … [4] Goswami M,
Verma A, Verma M. Benign migratory glossitis with fissured tongue …
 |  |  |
The Prevalence of Tongue Anomalies among Medium School Pupils at Aged 13-15 Years Old in Fallujah City, Iraq
AH Abed, MI Abdullah, ANH Warwar - Journal of Research in Medical and Dental …, 2018
… 22. The prevalence of all tongue anomalies was 30.12% (fissured tongue 8.2%,
geographic tongue 2.12%, Macroglossia 2%, tongue tie 10.9%, median rhomboid
glossitis 0.42%, hairy tongue 0.2% and coated tongue 6.2%) …
geographic tongue 2.12%, Macroglossia 2%, tongue tie 10.9%, median rhomboid
glossitis 0.42%, hairy tongue 0.2% and coated tongue 6.2%) …
| | |
[PDF] CORRELATION BETWEEN PERIODIC PREVALENCE OF GEOGRAPHIC TONGUE AND ALLERGIC PHENOMENA IN PATIENTS ATTENDING ALBORZ CLINIC
M Jafary Heidarloo, G Aisan, L Same, N Sarafan - The Journal of Urmia University of …, 2018
Page 1. 673 ﻲﺸﻫﻭﮋﭘ ﻪﻟﺎﻘﻣ ﺷ ﯽﮕﺘﺴﺒﻤﻫ ناﺰﯿﻣ ﯿ عﻮ هرود اي و ﯽﯾﺎﯿﻓاﺮﻐﺟ نﺎﺑز ﺪﭘﯾ هﺪ ﺎﻫ ي نارﺎﻤﯿﺑ رد ﮏﯾژﺮﻟآ ﻪﻌﺟاﺮﻣ
هﺪﻨﻨﮐ لﺎﺳ رد ﻪﯿﻣورا نﺎﺘﺳﺮﻬﺷ زﺮﺒﻟا ﮏﯿﻨﯿﻠﮐ ﻪﺑ 1395 ﺮﻔﻌﺟ ﺪﻤﺤﻣ ﻱ ﺣﻴ ﻮﻟﺭﺪ ١ ﻥﺎﻓﺍﺮﺻ ﺭﺎﮕﻧ ، ٢ ﻟ ،ﻴ ﻊﻣﺎﺳ ﻼ ٣ ﺁ ،ﻳ ﻮﻧﺰﻏ
ﻥﺎﺴ ﻱ* ٤ ﺖﻓﺎﯾرد ﺦﯾرﺎﺗ 28 / 06 / 1396 شﺮﯾﺬﭘ ﺦﯾرﺎﺗ 07 / 09 / 1396 ﮑﭼ ﻩﺪﻴ …
هﺪﻨﻨﮐ لﺎﺳ رد ﻪﯿﻣورا نﺎﺘﺳﺮﻬﺷ زﺮﺒﻟا ﮏﯿﻨﯿﻠﮐ ﻪﺑ 1395 ﺮﻔﻌﺟ ﺪﻤﺤﻣ ﻱ ﺣﻴ ﻮﻟﺭﺪ ١ ﻥﺎﻓﺍﺮﺻ ﺭﺎﮕﻧ ، ٢ ﻟ ،ﻴ ﻊﻣﺎﺳ ﻼ ٣ ﺁ ،ﻳ ﻮﻧﺰﻏ
ﻥﺎﺴ ﻱ* ٤ ﺖﻓﺎﯾرد ﺦﯾرﺎﺗ 28 / 06 / 1396 شﺮﯾﺬﭘ ﺦﯾرﺎﺗ 07 / 09 / 1396 ﮑﭼ ﻩﺪﻴ …
| | |
Monotherapy with a novel intervenolin derivative, AS‐1934, is an effective treatment for Helicobacter pylori infection
T Ohishi, T Masuda, H Abe, C Hayashi, H Adachi… - Helicobacter, 2018
… For this reason, the eradication rates have been declining, falling below 80% in many
areas.5–7 In addition, the occurrence of adverse side effects such as diarrhea, abdominal pain,
urticaria, glossitis, and nausea/vomiting prevents patients from achieving therapeutic success …
areas.5–7 In addition, the occurrence of adverse side effects such as diarrhea, abdominal pain,
urticaria, glossitis, and nausea/vomiting prevents patients from achieving therapeutic success …
| | |
The oral mucosa: A barrier site participating in tissue‐specific and systemic immunity
NM Moutsopoulos, HM Moutsopoulos - Oral Diseases, 2018
… Gastrointestinal diseases, Crohn's disease, Oral Ulcers. Exocrine gland autoimmunity, Sjogren's
syndrome, Salivary gland malfunction/xerostomia/atrophic glossitis. Systemic autoimmunity,
Systemic lupus erythematosus, Oral mucosal lesions/xerostomia. Granulomatous polyangiitis …
syndrome, Salivary gland malfunction/xerostomia/atrophic glossitis. Systemic autoimmunity,
Systemic lupus erythematosus, Oral mucosal lesions/xerostomia. Granulomatous polyangiitis …
| | |
[HTML] Management protocols for dogs and cats intoxicated by zootoxins of the pine tree processionary
C Magro
… CONCLUSIONES / CONCLUSIONS. The poisoning of small animals by T. pityocampa
occurs usually during spring. This contact usually affects the oral cavity and can result
in a necrotizing glossitis in dogs with irreversible loss of tissue …
occurs usually during spring. This contact usually affects the oral cavity and can result
in a necrotizing glossitis in dogs with irreversible loss of tissue …
| | |
Methods of Treating Cancers, Autoimmune Disorders, and Other Conditions Associated with Chronic Inflammation
JR Williams - US Patent App. 15/558,094, 2018
In one aspect, a method of treating a disorder associated with chronic inflammation includes
administering to an individual in need thereof a therapeutically effective amount of isomyosmine
or a pharmaceutically acceptable salt thereof. In some aspects, the disorder is a cancer, an …
administering to an individual in need thereof a therapeutically effective amount of isomyosmine
or a pharmaceutically acceptable salt thereof. In some aspects, the disorder is a cancer, an …
| | |
[PDF] Child Health in India with Special Reference to North-East India
A Baruah - CHILD HEALTH IN INDIA
… Most of these causes are preventable. The various morbidities prevalent amongst the adolescent
girls were pallor, menstrual problems, dental caries, angular stomatitis, glossitis, bitot's spots,
skin problems, lymphadenopathy, diarrhoea, goitre etc. Page 31 …
girls were pallor, menstrual problems, dental caries, angular stomatitis, glossitis, bitot's spots,
skin problems, lymphadenopathy, diarrhoea, goitre etc. Page 31 …
| | |
Substituted n-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof
H Beck, T Thaler, R Kast, M Meininghaus, C Terjung… - US Patent App. 15/552,997, 2018
The present application relates to novel substituted N-bicyclo-2-arylquinoline-4-carboxamide
derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for
treatment and/or prevention of diseases, and to the use thereof for production of medicaments …
derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for
treatment and/or prevention of diseases, and to the use thereof for production of medicaments …
| | |
Solid Solution Compositions and Use in Chronic Inflammation
RM Bannister, J Brew, RR Reiley III, WC Wanderley - US Patent App. 15/794,214, 2018
The present specification discloses pharmaceutical compositions, methods of preparing such
pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or
an inflammatory disease in an individual using such pharmaceutical compositions.
pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or
an inflammatory disease in an individual using such pharmaceutical compositions.
| | |
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου